A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06907615 · RECRUITING
Trial details
- NCT number
- NCT06907615
- Sponsor
- Shanghai Henlius Biotech
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-09
- Primary completion
- 2028-04-20
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.